Novo Holdings A/S

Novo Holdings A/S (formerly Novo A/S) is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novonesis (formerly Novozymes A/S). Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation's assets, which by the end of 2024 was worth €142 billion (approximately US$165 billion). The company generated a total income and investment return of DKK 31 billion (€4.2 billion) in 2023 and DKK 60 billion (€8 billion) in 2024. By the end of 2024, Novo Holdings had a total of 181 companies in its investment portfolio.

It is the largest charitable foundation in the world making Novo Holdings A/S a world-leading life sciences investor. Novo Holdings is headquartered in Copenhagen, Denmark, with offices in San Francisco, Boston and Singapore.

Eivind Kolding succeeded Henrik Gürtler as CEO in May 2014. Kolding left Novo Holdings A/S in March 2016 and Kasim Kutay took over as CEO.